Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

48 recalls · Class III, newest first

Class III · Low risk

Wal-Tussin DM

Incorrect/Undeclared Excipient: Product contains alcohol

Terminated Chemical / undeclared AptaPharma Inc. NDC 0363-0324-28 D-0787-2022
Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-363-90 D-1106-2018
Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-362-90 D-1105-2018
Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-361-90 D-1104-2018
Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-360-30 D-1103-2018
Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-363-90 D-0876-2018
Class III · Low risk

Bull Capsules

Marketed without an Approved NDA/ANDA; product found to be tainted with sildenafil

Terminated Chemical / undeclared BYL Solutions Inc. D-0414-2018
Class III · Low risk

Norethindrone Acetate and Ethinyl Estradiol Tablets

Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room.

Terminated Chemical / undeclared Mylan Pharmaceuticals Inc. NDC 0378-7280-85 D-0861-2017
Class III · Low risk

Tarina Fe 1/20

Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room.

Terminated Chemical / undeclared Mylan Pharmaceuticals Inc. NDC 50102-128-01 D-0860-2017
Class III · Low risk

Fenofibric Acid Tablets 105 mg

Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.

Terminated Chemical / undeclared Tribute Pharmaceuticals US Inc. NDC 13310-102-07 D-0017-2016
Class III · Low risk

Fenofibric Acid Tablets

Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.

Terminated Chemical / undeclared Tribute Pharmaceuticals US Inc. NDC 13310-101-07 D-0016-2016
Class III · Low risk

ClomiPHENE CITRATE Tablets

Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.

Terminated Chemical / undeclared EMD Serono, Inc. NDC 0093-0041-03 D-1813-2015
Class III · Low risk

Imipramine HCl Tablets

Chemical Contamination; benzophenone leached from the product label varnish

Terminated Chemical / undeclared Mutual Pharmaceutical Company, Inc. NDC 54738-914-01 D-1425-2015
Class III · Low risk

Imipramine HCl Tablets

Chemical Contamination; benzophenone leached from the product label varnish

Terminated Chemical / undeclared Mutual Pharmaceutical Company, Inc. NDC 54738-913-01 D-1424-2015

Recalls by year